http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112831499-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d9de52bba13e16028dffa8775e3f3f28
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-127
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7088
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
filingDate 2021-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf402f71a447b720a726f3bbbbc1e864
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d39e351a3574fe1490bda8fec51d666f
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-112831499-A
titleOfInvention DNA origami-based binary deoxyribozyme structure and its preparation method and application
abstract The invention provides a DNA origami-based binary deoxyribozyme structure and a preparation method and application thereof. The preparation method comprises: forming a DNA origami structure by annealing; The enzyme strand b is embedded in the DNA origami structure; the helper chain is added to promote the successful assembly of the dimeric deoxyribozyme on the DNA origami structure; the double-labeled substrate strand is added to verify the efficient assembly of the dimeric deoxyribozyme by the fluorescent signal Due to the effect of the confinement space of the DNA origami structure, the present invention improves the collision probability between the helper chain and the streptases a and b by embedding the two-part deoxyribozyme on the DNA origami structure, and also reduces the energy of hybridization. The potential barrier allows the two-part DNAzyme to be assembled on the DNA origami structure; because the double-labeled reporter substrate can be used universally, it not only effectively reduces the DNA sequence requirements for streptases a and b, but also reduces the complexity of multiplex analysis. synthetic cost.
priorityDate 2021-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008054834-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID888
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ20EU8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ06SH2
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP96471
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426149262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9815560
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9TKU7
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ1KVQ9

Total number of triples: 26.